Head of Oncology
Linda brings to her role as Head of the Oncology Team a wealth of experience obtained from over 25 years in the global pharmaceutical industry, with particular depth and breadth in the oncology arena. Working for AstraZeneca, she was initially Project Director for Iressa® in first registrations, and latterly Head of Strategy and Portfolio for the Oncology and Infection Therapy Area Management Team. She was also SVP Portfolio and Project Integration (PPI) at Merck KGaA, leading the portfolio steering committee for oncology development programmes. Now with TranScrip, she is leading clinical development, registration and medical affairs programmes in Oncology.